Product NDC: | 59627-002 |
Proprietary Name: | AVONEX |
Non Proprietary Name: | interferon beta-1a |
Active Ingredient(s): | 30 ug/1 & nbsp; interferon beta-1a |
Administration Route(s): | INTRAMUSCULAR |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 59627-002 |
Labeler Name: | Biogen Idec MA Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | BLA103628 |
Marketing Category: | BLA |
Start Marketing Date: | 20030523 |
Package NDC: | 59627-002-05 |
Package Description: | 4 INJECTION, SOLUTION in 1 CARTON (59627-002-05) |
NDC Code | 59627-002-05 |
Proprietary Name | AVONEX |
Package Description | 4 INJECTION, SOLUTION in 1 CARTON (59627-002-05) |
Product NDC | 59627-002 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | interferon beta-1a |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAMUSCULAR |
Start Marketing Date | 20030523 |
Marketing Category Name | BLA |
Labeler Name | Biogen Idec MA Inc. |
Substance Name | INTERFERON BETA-1A |
Strength Number | 30 |
Strength Unit | ug/1 |
Pharmaceutical Classes | Interferon-beta [Chemical/Ingredient],Recombinant Human Interferon beta [EPC],Recombinant Proteins [Chemical/Ingredient] |